Search filters

List of works by Susan L. Cohn

'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis

scientific article

3 + 3 ≠ (Rolling) 6

scientific article published on 01 January 2008

5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma

scientific article published on 18 December 2019

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

scientific article

A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia

article

A Selfless Act

scientific article published on 10 August 2015

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project

scientific article published on 18 November 2020

A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.

scientific article

A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors

scientific article

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

scientific article published on 21 January 2013

A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study

scientific article published in October 2012

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

scientific article

Activity of a 40kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma ⬇️

scientific article published on October 1, 1997

Advances in Risk Classification and Treatment Strategies for Neuroblastoma

scientific article

Advances in the diagnosis and treatment of neuroblastoma

scientific article

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group

scientific article

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

scientific article

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

scientific article

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study

scientific article

Are molecular neuroblastoma classifiers ready for prime time?

scientific article published on 01 July 2009

Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients

scientific article published on 25 July 2020

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

scientific article published in December 2004

Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma

scientific article

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study

scientific article

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project

scientific article

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project

scientific article published on 01 December 2011

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

scientific article published on 19 December 2012

Chromosome 1p and 11q deletions and outcome in neuroblastoma

scientific article

Clinical Impact and Prognostic Value of Metaiodobenzylguanidine Imaging in Children With Metastatic Neuroblastoma

scientific article published on 01 January 1999

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project

scientific article

Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro

scientific article published on January 2010

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group

scientific article published on February 2008

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project

scientific article

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

scientific article published on October 2009

Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day.

scientific article

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy

scientific article published on 20 January 2016

Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology

scientific article published on September 2017

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

scientific article

Data Commons to Support Pediatric Cancer Research

scientific article

De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

scientific article published on 04 May 2009

Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.

scientific article

Differential Activity of ELAV-like RNA-binding Proteins in Human Neuroblastoma

scientific article published in Journal of Biological Chemistry

Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.

scientific article

Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study

scientific article published on 01 October 2006

Emerging and investigational therapies for neuroblastoma.

scientific article published on 17 March 2017

Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects

scientific article

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

scientific article

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma

scientific article published in October 2017

Evidence for Molecular Heterogeneity in Human Ganglioneuroblastoma

article

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

article

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

article

Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma

scientific article

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

scientific article

Expression of the putative tumour suppressor gene,p73, in neuroblastoma and other childhood tumours

article

Gastrointestinal relapse of leukemia, mimicking acute graft vs. host disease, following a stem cell transplant

scientific article published on 01 April 2000

Genetic discoveries and treatment advances in neuroblastoma

scientific article

Genetically InFormed therapies--a "GIFT" for children with cancer

scientific article

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project

scientific article published on 17 May 2011

High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene

scientific article

HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN RNA.

scientific article

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

article

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

scientific article

Immune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of Immunotherapy

scientific article published on 27 November 2017

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients

scientific article

Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients

scientific article

International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions

scientific article

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

scientific article published on May 2009

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

Locoregional MYCN-amplified neuroblastoma

scientific article published on 01 January 2012

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group

scientific article published in April 1997

Long-term outcome of patients with intraspinal neuroblastoma

scientific article published on 01 May 1999

Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

scientific article published on 15 December 2017

MYCN amplification remains prognostically strong 20 years after its “clinical debut”

scientific article published on 01 December 2004

MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.

scientific article published on January 2004

Management of tumor lysis syndrome: need for evidence-based guidelines

scientific article

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma

scientific article published on 23 January 2019

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database

scientific article

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

scientific article

Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma

scientific article published on July 2004

Modulation of matrix remodeling by SPARC in neoplastic progression

scientific article published on December 2009

Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study

scientific article

Neuroblastoma

scientific article published in The Lancet

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

scientific article published on 2 October 2017

Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.

scientific article published in October 2004

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project

scientific article

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group

scientific article

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

scientific article published on 26 December 2016

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review

scientific article

Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma

scientific article published on 07 April 2011

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

scientific article

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

scientific article

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy

scientific article published in December 2005

Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient

scientific article published on 30 May 2020

Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients

scientific article published on 5 July 2016

Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research

scientific article published on 18 October 2021

Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

scientific article

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.

scientific article published in January 2010

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

scientific article

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

scientific article published on 09 August 2018

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study

scientific article

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group

scientific article published on 9 September 2011

Physician specialization and antiretroviral therapy for HIV.

scientific article

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study

scientific article published on 17 October 2011

Positive association between congenital anomalies and risk of neuroblastoma

scientific article published on 01 October 2005

Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas

scientific article

Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors

scientific article

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database

scientific article

Prognostic significance ofEPHB6, EFNB2, andEFNB3 expressions in neuroblastoma

scientific article published on 01 December 2000

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

scientific article published on 3 October 2011

Progress in Defining and Treating High-Risk Neuroblastoma: Lessons From the Bench and Bedside

scientific article published on 26 January 2009

Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.

scientific article published on 5 November 2012

Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma

scientific article published on 01 June 2007

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

scientific article published on 25 July 2013

Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study

scientific article

Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.

scientific article

Residential Pesticide Exposure and Neuroblastoma

article

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

scientific article published on 4 May 2017

Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma

scientific article published in March 2008

SPARC enhances tumor stroma formation and prevents fibroblast activation

scientific article published on 29 January 2007

SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix

scientific article

Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo

scientific article published on 01 December 2000

Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma

scientific article published in October 2004

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy

scientific article

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

scientific article

Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids

scientific article published on 20 October 2016

Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone

scientific article

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence

scientific article published on 10 February 2016

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project ⬇️

scientific article published on September 13, 2012

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group

scientific article

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database

scientific article published in December 2008

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project

scientific article

Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus

article

Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth

scientific article

Specialty training and specialization among physicians who treat HIV/AIDS in the United States

scientific article

Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma

scientific article published on 14 July 2015

Surveillance of Childhood Cancer Survivors: A Lifelong Affair

article

Synergy between 5′ and 3′ flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cells

article

T-cell prolymphocytic leukemia: a single-institution experience

scientific article published on 01 November 2005

TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma

scientific article published on 15 May 2014

Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future

scientific article published on 01 October 2020

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma

scientific article published on 12 September 2012

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

scientific article published on December 2008

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

scientific article published in December 2008

The MYCN enigma: significance of MYCN expression in neuroblastoma

scientific article published on March 2006

The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy

scientific article

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

scientific article published on 30 May 2020

The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth

scientific article published on January 2011

The regulation of angiogenesis in neuroblastoma

scientific article

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives

scientific article

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma

scientific article published on February 2007

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

scientific article published on 18 December 2013

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival

scientific article published on 14 December 2012

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

article

Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital

scientific article published in July 2004

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

scientific article

Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma

scientific article

Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression

scientific article published on 19 September 2012

Using Germline Genomics to Individualize Pediatric Cancer Treatments ⬇️

scientific article published on May 15, 2012

Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system

scientific article published on 31 January 2014

Paulina is supported by:

About Paulina

Help